MedTrace Logo

NaviCam Patency Capsule to Verify Gastrointestinal Patency

NCT07649720 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-06-16

No results posted yet for this study

Summary

Participants included in this study will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm weather the capsule is still in the body.

Conditions

  • Intestinal Stricture
  • Crohn Disease
  • NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy
  • Abdominal Pain

Interventions

DEVICE

NaviCam Patency Capsule

The NaviCam Patency Capsule is an accessory to the NaviCam capsule and is intended to verify adequate patency of the gastrointestinal tract prior to administration of the NaviCam capsule in patients with known or suspected strictures.

Sponsors & Collaborators

  • AnX Robotica Corp.

    lead INDUSTRY

Principal Investigators

  • Rockford G Yapp, MD · Digestive Health Services

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2026-12-15
Completion
2027-03-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07649720 on ClinicalTrials.gov